Health

FDAnews Announces — Latest Medical Device Postmarket Surveillance Requirements from China’s NMPA and the U.S. FDA Webinar Nov. 12, 2020

Leave a comment


WCG FDAnews

WCG FDAnews


FALLS CHRUCH, Va. (PRWEB)

Latest Medical Device Postmarket Surveillance Requirements from China’s NMPA and the U.S. FDA

An FDAnews Webinar

Thursday, Nov. 12, 2020, 1:30 p.m.-3:00 p.m. EST

https://www.fdanews.com/mdpostmarketsurveillance

Get up to speed on the hundreds of new regulations introduced by China’s National Medical Products Administration (NMPA).

What are the latest requirements for postmarket surveillance (PMS) and quality management systems (QMS)?

Join us on Nov. 12 and get up to speed on the regulatory reform in China that impacts the medical device and IVD industry.

During the webinar, attendees will:


  • Learn about the latest requirements and regulations for PMS and QMS in the NMPA and FDA

  • Discover how to assess and determine the new piloted marketing authorization holder (MAH) system by understanding its MAH qualification requirements and responsibilities

  • Familiarize oneself with how to leverage overseas QMS for China operations by understanding China GMP regulations and Chinese culture differences

  • Find out how to comply with required adverse events (AE) and serious adverse events (SAE) reports, including how to differentiate between AE and SAE and when to report

Join us for clarity on China’s regulatory reforms impacting the medical device and IVD industry.

Interested in registering multiple sites?

Call (888) 838-5578 in the U.S. or +1 (703) 538-7600 globally to learn about our special multisite discount.

Webinar Details:

Latest Medical Device Postmarket Surveillance Requirements from China’s NMPA and the U.S. FDA

An FDAnews Webinar

Thursday, Nov. 12, 2020, 1:30 p.m.-3:00 p.m. EST

https://www.fdanews.com/mdpostmarketsurveillance

Tuition:

$287 per site

Easy Ways to Register:

Online: https://www.fdanews.com/mdpostmarketsurveillance

By phone: 888.838.5578 or 703.538.7600

About FDAnews:

FDAnews is the premier provider of domestic and international regulatory, legislative, and business news and information for executives in industries regulated by the US FDA and the European Medicines Agency. Pharmaceutical and medical device professionals rely on FDAnews’ print and electronic newsletters, books and conferences to stay in compliance with international standards and the FDA’s complex and ever-changing regulations

Share article on social media or email:

Leave a Reply